In a patient taking aspirin who has non‑traumatic bruising on the right leg, normal platelet count, and a negative venous duplex ultrasound, what is the likely cause and recommended management?

Non-Traumatic Bruising on Aspirin with Normal Platelets and Negative Venous Ultrasound

This is most likely aspirin-induced platelet dysfunction causing easy bruising, which is an expected and generally benign side effect of aspirin therapy that does not require discontinuation unless bleeding becomes clinically significant.

Understanding the Clinical Picture

The combination of non-traumatic bruising in a patient on aspirin with normal platelet count and negative venous ultrasound points to aspirin's antiplatelet effect as the primary culprit. Aspirin irreversibly inhibits cyclooxygenase-1 (COX-1), preventing thromboxane A2 synthesis and impairing platelet function for the entire 10-day lifespan of affected platelets 1. This creates a mild systemic hemostatic defect that manifests as easy bruising in many patients.

The FDA label explicitly warns that aspirin may cause bleeding complications, with increased risk in patients over 60, those with bleeding history, or those taking other anticoagulants 2. However, spontaneous bleeding complications outside the gastrointestinal tract rarely result from aspirin use in otherwise hemostatically normal individuals 3.

Key Diagnostic Considerations

Your workup has appropriately ruled out:

• Thrombocytopenia (normal platelet count)
• Deep vein thrombosis (negative venous ultrasound)

What remains is determining whether this represents:

1. Expected aspirin effect (most likely): Aspirin causes platelet dysfunction in all users; some patients simply bruise more visibly
2. Underlying platelet disorder unmasked by aspirin: Antiplatelet therapy can reveal previously subclinical inherited bleeding disorders 4
3. "Easy bruising syndrome": A recognized entity in patients with normal coagulation profiles, more common in women, sometimes associated with platelet function abnormalities or antiplatelet antibodies 5

Management Algorithm

Step 1: Assess Clinical Significance

• If bruising is mild, cosmetic only, and not associated with mucosal bleeding, hematuria, or significant hematomas: Continue aspirin if there is a valid indication
• If bruising is extensive, associated with other bleeding manifestations, or causing significant concern: Proceed to Step 2

Step 2: Verify Aspirin Indication

Review why the patient is on aspirin:

• Secondary cardiovascular prevention (prior MI, stroke, stent): Continue aspirin - the thrombotic risk of discontinuation far outweighs bruising concerns 1
• Primary prevention in low-moderate risk patients: Consider discontinuation - recent guidelines (2022 USPSTF) recommend against routine aspirin for primary prevention due to bleeding risks that often outweigh benefits 6, 7, 8

Step 3: Consider Further Testing (if bleeding seems excessive)

If bruising appears disproportionate to aspirin's expected effect:

• Platelet function testing: May reveal underlying platelet dysfunction (impaired epinephrine or ADP aggregation) 5
• Coagulation studies beyond PT/aPTT: Consider von Willebrand factor, factor levels if family history suggests inherited disorder 9
• Hematology consultation: Recommended when suspicion remains high despite normal initial workup 9

Practical Recommendations

Do NOT discontinue aspirin reflexively for bruising alone if the patient has:

• Prior myocardial infarction
• Prior stroke or TIA
• Coronary stents
• Established cardiovascular disease

The guidelines emphasize that aspirin discontinuation in these populations carries significant thrombotic risk 1.

DO consider aspirin discontinuation if:

• Aspirin is for primary prevention only (no established CVD)
• Patient is over 60 with no clear cardiovascular benefit
• Bruising is accompanied by other bleeding manifestations
• Patient has concurrent anticoagulation or high bleeding risk

Common Pitfalls to Avoid

1. Don't assume all bruising on aspirin is pathologic: Mild bruising is an expected pharmacologic effect 3, 10
2. Don't order unnecessary platelet function tests: These are not routinely indicated for simple bruising and have inconsistent correlation with bleeding risk 1
3. Don't stop aspirin without assessing cardiovascular risk: The thrombotic consequences can be life-threatening in secondary prevention patients 1
4. Don't miss nonaccidental trauma: Consider this in vulnerable populations presenting with unexplained bruising 9

Bottom Line

Continue aspirin if indicated for secondary cardiovascular prevention and reassure the patient that mild bruising is expected. Only pursue further workup if bleeding manifestations are excessive or if aspirin is being used for primary prevention where discontinuation is reasonable. The normal platelet count and negative ultrasound have already excluded the most concerning alternative diagnoses.